A Calgary-developed wound treatment is being used to help treat people wounded in Ukraine, with outlets describing its use in battlefield care and burn-related injuries. The product is presented as a gel designed to fight bacteria and support tissue regeneration, with particular emphasis on speeding aspects of burn healing such as skin grafting.
Several sources tie the technology to NanoSALV/Catalytic and describe how it received Health Canada approval. One report also says the treatment was evaluated domestically in communities, including unhoused people in encampments, before it was highlighted for use in Ukraine. Coverage focuses both on medical function—such as reducing bacterial risk and promoting healing—and on how accessible the product is.
Angles differ on whether the story leads with the war-in-Ukraine impact or with the domestic health-tech context, including mention of slow adoption within Canada. The overall emphasis remains that the Calgary innovation is now reaching patients beyond Canada, particularly those needing wound care in conflict settings.
